Last reviewed · How we verify
NCT06222333
Breathing Exercise for Rib Fracture
NA trial testing Respiratory physiotherapy in Rib Fractures in 62 participants. Currently enrolling.
1 April 2025
Quick facts
| Lead sponsor | Kastamonu University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 62 |
| Start date | 13 November 2024 |
| Primary completion | 1 April 2025 |
| Estimated completion | 1 April 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Respiratory physiotherapy
- Conservative Treatment — full drug profile →
Conditions studied
- Rib Fractures — all drugs for Rib Fractures →
- Spirometry — all drugs for Spirometry →
Sponsor
Kastamonu University
Who can join
Adults 18 to 100, any sex, with Rib Fractures or Spirometry. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Respiratory physiotherapy is routinely performed after thoracic surgery operations to increase lung expansion and prevent pulmonary complications such as atelectasis and pneumonia. It is a controversial issue whether respiratory physiotherapy reduces pulmonary complications in rib fractures. In our study, patients with rib fractures will be divided into two groups. In the control group, standard treatment consisting of routine analgesic treatments will be applied. In the other group, respiratory physiotherapy will be applied with triflu for 8 hours a day. At the end of the study, pulmonary complications in both groups will be compared.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06222333
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Respiratory physiotherapy
Trials testing the same drug.
- NCT06615934 — Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients · NA · not yet recruiting
- NCT05031858 — Effect of Vojta Therapy on Covid-19 Respiratory Disease · NA · unknown
- NCT04395937 — SAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Tra · NA · recruiting
- NCT04459819 — Respiratory Physiotherapy in Severe COVID-19 Patients · completed
- NCT03835858 — Safety of Airway Clearance in Non-hospitalized Infants With Acute Viral Bronchiolitis · NA · completed
Other recruiting trials for Rib Fractures
Currently open trials in the same condition.
- NCT05642026 — INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures · Phase 4 · recruiting
- NCT06853002 — Deep Breathing Exercises and Incentive Spirometry After Rib Fracture · NA · recruiting
- NCT06347874 — Cryo Rib Fracture Study · Phase 4 · recruiting
- NCT06519929 — Analgesic Techniques for Rib Fractures · Phase 4 · active not recruiting
- NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting
Other Kastamonu University trials
Trials by the same sponsor.
- NCT07293845 — Can Nursing Students' Knowledge and Attitudes Toward Climate Change · NA · not yet recruiting
- NCT07327112 — Evaluation of the Anterior Tibialis Tendon Using Elastography in Patients With Hallux Valgus · not yet recruiting
- NCT07399548 — Effects of 8-Week Plyometric Training on Basketball Performance and Isokinetic Strength · NA · completed
- NCT07098962 — KinesioTaping for Thoracic Drain Support · Phase 2, PHASE3 · completed
- NCT07057752 — Virtual Reality for Pain and Anxiety Relief During Peripheral Angioplasty · Phase 2, PHASE3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06222333 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kastamonu University
- Last refreshed: 14 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06222333.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing